Estonia vs South Africa: Life science patents granted, by technology
Estonia
1 patents
in 2018
South Africa
2 patents
in 2023
Estonia rank
55th
South Africa rank
52nd
Life science patents granted, by technology over time
- Estonia
- South Africa
How they compare
South Africa currently reports 2 patents against 1 patents in Estonia, a difference of 1 patents.
That makes South Africa's figure about 2.0 times Estonia's.
Across all 23 years both countries report, South Africa has been ahead every year.
Estonia ranks 55th and South Africa ranks 52nd of 65 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Estonia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 18.5 patents | 622.25 patents | 603.75 patents | South Africa |
| 2000s | 49.2 patents | 712.2 patents | 663 patents | South Africa |
| 2010s | 13.89 patents | 268.11 patents | 254.22 patents | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Estonia or South Africa?
- South Africa, at 2 patents against 1 patents in Estonia as of 2023.
- What is the difference in life science patents granted, by technology between Estonia and South Africa?
- 1 patents, with South Africa ahead.
- How many years of comparable data are there for Estonia and South Africa?
- 23 years are reported by both, from 1996 to 2018.
- How do Estonia and South Africa rank globally for life science patents granted, by technology?
- Estonia ranks 55th and South Africa ranks 52nd of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) β processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.